2005
Delivering Pneumococcal Vaccine to a High Risk Population: The Navajo Experience
Benin AL, Watt JP, O'Brien KL, Reid R, Zell ER, Katz S, Donaldson C, Schuchat A, Santosham M, Whitney CG. Delivering Pneumococcal Vaccine to a High Risk Population: The Navajo Experience. Human Vaccines & Immunotherapeutics 2005, 1: 66-69. PMID: 17038821, DOI: 10.4161/hv.1.2.1562.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedArizonaCross-Sectional StudiesDelivery of Health CareFemaleHumansImmunization ProgramsIndians, North AmericanMaleMiddle AgedNew MexicoPneumococcal InfectionsPneumococcal VaccinesPopulation SurveillanceRiskSample SizeUnited StatesUnited States Public Health ServiceUtahConceptsIndian Health ServiceVaccine indicationsVaccination programHealth servicesPneumococcal polysaccharide vaccineHealthy People 2010High-risk populationPublic health nursingCross-sectional studyNavajo adultsPneumococcal diseasePneumococcal vaccinePolysaccharide vaccineMedical chartsPreventable diseaseHealth nursingPersons 18Home visitsRisk populationsUniversal health insuranceExcellent delivery systemHealth insuranceNavajo patientsVaccineHigh rate
2003
Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults
Benin AL, O'Brien KL, Watt JP, Reid R, Zell ER, Katz S, Donaldson C, Parkinson A, Schuchat A, Santosham M, Whitney CG. Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults. The Journal Of Infectious Diseases 2003, 188: 81-89. PMID: 12825175, DOI: 10.1086/375782.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseOverall vaccine effectivenessNavajo adultsPneumococcal diseaseCase patientsControl patientsPolysaccharide vaccineVaccine effectivenessGeneral United States populationSerious pneumococcal diseasePneumococcal polysaccharide vaccineCohort methodologyUnited States populationCase-control setsActive surveillanceObservational studyMedical conditionsPatientsMedical careDiseaseAdultsDiabetesRegression analysisVaccineAlcoholism